Actively Recruiting
A Prospective Clinical Registry Evaluating Safety and Performance of Teleflex Vascular Access Devices
Led by Teleflex · Updated on 2025-08-07
2500
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting detailed data on how well Teleflex's vascular access devices perform and how safe they are when used in everyday medical care. This observational registry aims to gather high-quality evidence on devices like central venous catheters, midline catheters, peripheral catheters, hemodialysis catheters, and arterial catheters, including some with antimicrobial and antithrombogenic features. The study focuses on real-world use following the devices' instructions for use to assess their safety and success. Participants in this registry will have a Teleflex vascular access device placed as part of their therapy or diagnosis. These devices range from central venous catheters to accessories used for their placement and maintenance. The study will observe and record the use of these devices without altering standard care, tracking outcomes such as successful device use and verification of catheter tip positioning. During the study, participants will be monitored for device-related adverse events within seven days after device removal. Data collection will include whether the device was successfully used without needing removal due to complications and confirmation of catheter tip location immediately after removal for certain devices. The registry aims to provide comprehensive real-world safety and performance data over the course of the study, which starts in December 2024 and extends to December 2034.
CONDITIONS
Brief Title
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects will undergo a procedure that includes use of a Teleflex device covered by this research
- Subject is willing and capable of providing informed consent or legally authorized representative consent
- Subjects can read and understand English or Spanish
You will not qualify if you...
- Subject is currently participating in another clinical registry or investigation that may affect this study
- Subject previously failed screening or was enrolled in this registry
- Subject is imprisoned
- Subject is cognitively impaired and unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of device use until removal
Participants undergo placement of a Teleflex vascular access device as part of their routine care, which is observed in this registry.
Visits occur as part of routine clinical care during device placement and maintenance
Duration - Up to 7 days after device removal
Participants are monitored for device performance and any device-related adverse events after device removal.
Approximately 1 to 2 follow-up visits within 7 days after device removal
Trial Site Locations
Total: 3 locations
1
Huntsville Hospital
Huntsville, Alabama, United States, 35801
Actively Recruiting
2
Loma Linda University Health
Loma Linda, California, United States, 92354
Actively Recruiting
3
Tufts Medical Center
Boston, Massachusetts, United States, 02111
Actively Recruiting
Research Team
A
Aderinola (Derin) Ogundimu, PhD, ACRP, PMP
T
Thomas E. Philbeck, Jr., PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here